Analytical Data
-
Gene name
OIP5
- Application
-
Alternative Names
OIP5; MIS18B; Protein Mis18-beta; Cancer/testis antigen 86; CT86; Opa-interacting protein 5; OIP-5
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
O43482
-
Expression Region
1-229 aa
-
AA Sequence
MAAQPLRHRS RCATPPRGDF CGGTERAIDQ ASFTTSMEWD TQVVKGSSPL GPAGLGAEEP AAGPQLPSWL QPERCAVFQC AQCHAVLADS VHLAWDLSRS LGAVVFSRVT NNVVLEAPFL VGIEGSLKGS TYNLLFCGSC GIPVGFHLYS THAALAALRG HFCLSSDKMV CYLLKTKAIV NASEMDIQNV PLSEKIAELK EKIVLTHNRL KSLMKILSEV TPDQSKPEN
-
Molecular Weight
24.6 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
OIP5 (Opa interacting protein 5) is a recently characterized protein that plays a significant role in various cellular processes, including cell cycle regulation and mitosis. Its name derives from its interaction with the Opa protein, which is implicated in the pathogenesis of Neisseria gonorrhoeae. The exploration of OIP5 as a potential regulator of cellular events has gained traction due to its involvement in numerous diseases, including cancer. Studies have indicated that OIP5 may affect the progression of cancer by modulating pathways related to cell proliferation and apoptosis. Furthermore, aberrant expression of OIP5 has been associated with poor prognosis in various malignancies, making it an attractive target for therapeutic intervention. Given the increasing recognition of the importance of understanding such proteins in the context of disease, researchers are focusing on the structural and functional characterization of OIP5 to elucidate its mechanisms of action. The ongoing investigations aim not only to clarify the biological roles of OIP5 but also to evaluate its potential as a biomarker for disease diagnosis and prognosis, as well as a target for novel therapeutic strategies. This research underscores the importance of OIP5 in cellular biology and its relevance in translational medicine.
